§ Mr. Carter-Jonesasked the Secretary of State for Social Services (1) what representations he has received concerning the availability of Naudicelle on prescription for sufferers of multiple sclerosis; and if he will make a further statement;
(2) what research is currently being undertaken on the efficacy of Naudicelle in the treatment of multiple sclerosis, whether funded from Government sources or elsewhere; and if he will make a further statement;
(3) if he will make a statement on the outcome of the trial of Naudicelle at the Royal Victoria Infirmary, Newcastle.
§ Mr. MoyleI would refer my hon. Friend to my reply to my hon. Friend the Member for Ipswich (Mr. Weetch) and the hon. Member for Antrim, North (Rev. Ian Paisley) on 20th June 1977—[Vol. 933, c.372–3]—and to my subsequent letters to them dated 21st June 1977, copies of which were placed in the Library.
553WI understand that a clinical trial of the effects of Naudicelle capsules in the management of multiple sclerosis, funded by the Multiple Sclerosis Society of Great Britain and Northern Ireland, is being conducted at the Royal Victoria Infirmary, Newcastle upon Tyne. A report is expected shortly. I am informed that the Chairman of the Advisory Committee on Borderline Substances is in touch with the doctor in charge of the trial.